FundPlus

NOVADIP Biosciences S.A. raised $23M on November 3, 2022

Investors: -, Vives Louvain Technology Fund, INVESTSUD (Capital & Croissance) and FundPlus

AstriVax raised $30M on August 25, 2022

Investors: KU Leuven Innovation & Entrepreneurship, V-Bio Ventures, Merieux Equity Partners, Ackermans & van Haaren, Thuja Capital, BNP Paribas Fortis and FundPlus

Undisclosed raised $39M on August 23, 2022

Investors: Grand Patika, EQT Life Sciences, Novalis LifeSciences LLC, Omega Funds and FundPlus

Minoryx Therapeutics raised $55M on May 31, 2022

Investors: COLUMBUS VENTURE PARTNERS,S.G.E.I.C., S.A.U., Ysios Capital, CDTI, Centre for the Development of Industrial Technology and FundPlus

Tubulis GmbH raised $63M on May 3, 2022

Investors: Evotec, Andera Partners, OCCIDENT, Bayern Kapital GmbH, High-Tech Gründerfonds, BioMedPartners, coparion, Seventure Partners and FundPlus

TargED Biopharmaceuticals raised $44M on February 19, 2022

Investors: Utrecht Holdings (Universiteit Utrecht), Andera Partners, Inkef, Sunstone Life Science Ventures, Hadean Ventures, Curie Capital BV and FundPlus

EyeD Pharma raised $51M on December 24, 2021

Investors: SRIW, -, NOMAINVEST, SFPI-FPIM and FundPlus

NOVADIP Biosciences S.A. raised $22M on October 28, 2021

Investors: -, INVESTSUD (Capital & Croissance), Vives Louvain Technology Fund and FundPlus

Egle Therapeutics raised $47M on October 22, 2021

Investors: Bioqube Ventures, Takeda UK Limited, EQT Life Sciences and FundPlus

Cardior Pharmaceuticals raised $75M on August 25, 2021

Investors: coparion, BioMedPartners, Sunstone Partners, Inkef, EQT Life Sciences, Hadean Ventures, Bristol-Myers Squibb, UK and FundPlus